SANOFI

Sanofi India Share PriceSanofi India

₹8,218.75
175.05 (2.18%)
  • Advice
  • Hold
As on 02 December, 2023 | 21:38 BSE: 500674 NSE: SANOFIISIN: INE058A01010

Sanofi India Performance

Day Range

  • Low 8,001.30
  • High 8,236.00
₹ 8,218.75

52 Week Range

  • Low 5,202.10
  • High 8,236.00
₹ 8,218.75
  • Open Price8,050.00
  • Previous Close8,043.70
  • Volume19915

Start SIP in Sanofi India

Start SIP

Sanofi India Share Price

  • Over 1 Month 8.24%
  • Over 3 Month 15.5%
  • Over 6 Month 20.17%
  • Over 1 Year 44.51%

Sanofi India Key Statistics

P/E Ratio 31.7
PEG Ratio 11.3
Market Cap Cr 18,928
Price to Book Ratio 14.8
EPS 228.4
Dividend 4.6
Relative Strength Index 82.55
Money Flow Index 78.98
MACD Signal 129.7
Average True Range 143.49

Sanofi India Investment Rating

  • Master Rating:
  • Sanofi India Ltd has an operating revenue of Rs. 2,157.18 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 31% is great, ROE of 48% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 22% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 8% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 74 which is a FAIR score but needs to improve its earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 64 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sanofi India Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 715706737672692699707
Operating Expenses Qtr Cr 506528507505510538513
Operating Profit Qtr Cr 208178230167182161195
Depreciation Qtr Cr 10101010101111
Interest Qtr Cr 0100100
Tax Qtr Cr 58617360524587
Net Profit Qtr Cr 152123190131131120238
IndicatorDec 2022
Total Revenue Annual Cr 2,842
Operating Expenses Annual Cr 2,066
Operating Profit Annual in Cr 704
Depreciation Cr 42
Interest Annual Cr 2
Tax Annual Cr 244
Net Profit Annual Cr 621
IndicatorDec 2022
Cash from Operating Activity Annual Cr 399
Cash from Investing Activity Annual Cr 651
Cash from Financing Annual Activity Cr -1,583
Net Cash Flow Annual Cr -533
IndicatorDec 2022
Total ShareHolders Funds Annual Cr 1,276
Fixed Assets Annual Cr 329
Total Non Current Assets Annual Cr 461
Total Current Assets Annual Cr 1,610
Total Assets Annual Cr 2,072
IndicatorDec 2022
Book Value Per Share Annual Rs 555
ROE Annual % 49
ROCE Annual % 55
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 28
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 715706737
Operating Expenses Qtr Cr 506528507
Operating Profit Qtr Cr 208178230
Depreciation Qtr Cr 101010
Interest Qtr Cr 010
Tax Qtr Cr 586173
Net Profit Qtr Cr 152123190
IndicatorDec 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorDec 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorDec 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorDec 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Sanofi India Technicals

EMA & SMA

Current Price
₹8,218.75
175.05 (2.18%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹7,856.42
  • 50 Day
  • ₹7,613.70
  • 100 Day
  • ₹7,330.19
  • 200 Day
  • ₹6,969.10
  • 20 Day
  • ₹7,845.55
  • 50 Day
  • ₹7,546.70
  • 100 Day
  • ₹7,310.05
  • 200 Day
  • ₹6,724.64

Sanofi India Resistance and Support

PIVOT
₹8,152.02
Resistance
First Resistance 8,302.73
Second Resistance 8,386.72
Third Resistance 8,537.43
RSI 82.55
MFI 78.98
MACD Single Line 129.70
MACD 154.94
Support
First Resistance 8,068.03
Second Resistance 7,917.32
Third Resistance 7,833.33

Sanofi India Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 20,745 1,269,387 61.19
Week 17,646 1,025,909 58.14
1 Month 20,000 1,271,009 63.55
6 Month 17,638 1,084,734 61.5

Sanofi India Result Highlights

Sanofi India Synopsis

NSE-Medical-Generic Drugs

Sanofi India is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2770.10 Cr. and Equity Capital is Rs. 23.00 Cr. for the Year ended 31/12/2022. Sanofi India Ltd. is a Public Limited Listed company incorporated on 02/05/1956 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1956PLC009794 and registration number is 009794.
Market Cap 18,929
Sales 2,829
Shares in Float 0.92
No of funds 188
Yield 2.36
Book Value 14.82
U/D Vol ratio 3.2
LTDebt / Equity
Alpha 0.15
Beta 0.13

Sanofi India

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 60.4%60.4%60.4%60.4%
Mutual Funds 9.97%9.55%9.53%9.4%
Insurance Companies 11.67%10.04%9.93%9.82%
Foreign Portfolio Investors 6.8%6.72%6.71%6.99%
Financial Institutions/ Banks
Individual Investors 8.6%8.89%9.29%9.13%
Others 2.56%4.4%4.14%4.26%

Sanofi India Management

Name Designation
Mr. Aditya Narayan Chairman
Mr. Rodolfo Hrosz Managing Director
Mr. Cherian Mathew Whole Time Director
Mr. Vaibhav Karandikar WholeTime Director & CFO
Mr. Charles Billard Non Executive Director
Mr. Marc Antoine Lucchini Non Executive Director
Ms. Usha Thorat Independent Director
Mr. Rahul Bhatnagar Independent Director
Ms. Annapurna Das Non Executive Director

Sanofi India Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sanofi India Corporate Action

Date Purpose Remarks
2023-11-08 Quarterly Results
2023-08-10 Quarterly Results
2023-05-10 Quarterly Results
2023-02-23 Audited Results & Dividend
2022-11-03 Quarterly Results
Date Purpose Remarks
2022-08-08 SPECIAL Rs.193.00 per share (1930%) One Time Special Interim Dividend

Sanofi India MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 37,319
Aditya Birla Sun Life Frontline Equity Fund Growth 23,003
Nippon India Multi Cap Fund - Growth 20,916
Nippon India Growth Fund - Growth 19,082
SBI Contra Fund Regular Payout Inc Dist cum Cap Wdrl 16,667

Sanofi India FAQs

What is Share Price of Sanofi India ?

Sanofi India share price is ₹8,218 As on 02 December, 2023 | 21:24

What is the Market Cap of Sanofi India ?

The Market Cap of Sanofi India is ₹18928.3 Cr As on 02 December, 2023 | 21:24

What is the P/E ratio of Sanofi India ?

The P/E ratio of Sanofi India is 31.7 As on 02 December, 2023 | 21:24

What is the PB ratio of Sanofi India ?

The PB ratio of Sanofi India is 14.8 As on 02 December, 2023 | 21:24

Q2FY23